Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has
been filed against Anavex Life Sciences Corp. (“Anavex” or the
“Company”) (Nasdaq: AVXL).
Investors who purchased or otherwise acquired shares between May 17,
2013 and December 28, 2015, inclusive (the “Class Period”) are
encouraged to contact the Firm prior to the February 29, 2016, lead
plaintiff motion deadline.
If you purchased shares of Anavex during the Class Period, please
contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman
Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by
email at joon@khanglaw.com.
There has been no class certification in this case. Until certification
occurs, you are not represented by an attorney. You may choose to take
no action and remain a passive class member.
According to the complaint, the Company issued misleading statements to
investors and/or failed to disclose that Anavex had used a paid stock
promoter to artificially inflate Anavex’s share price.
If you purchased shares of Anavex during the Class Period, you have
until February 29, 2016 to ask the Court to appoint you as lead
plaintiff. If you wish to learn more about this lawsuit, or if you have
any questions concerning this notice or your rights, please contact Joon
M. Khang, a prominent litigator for almost two decades, by telephone:
(949) 419-3834, or by email at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20160112006534r1&sid=ntxv4&distro=nx&lang=en)
View source version on businesswire.com: http://www.businesswire.com/news/home/20160112006534/en/
Copyright Business Wire 2016